FdaApplication
ANDA 205245
Identifiers
- fda_app_no: ANDA205245
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2015-09-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METRONIDAZOLE | METRONIDAZOLE | 250MG | TABLET;ORAL |
| METRONIDAZOLE | METRONIDAZOLE | 500MG | TABLET;ORAL |
2 products